What are Niagen Bioscience, Inc. Common Stock's profit margins?

Niagen Bioscience, Inc. Common Stock (NAGE) runs a 64.3% gross margin and a 10.0% operating margin, with a 14.3% net margin.

Where do Niagen Bioscience, Inc. Common Stock's ratios come from?

Every ratio is computed from Niagen Bioscience, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Niagen Bioscience, Inc. Common Stock NAGE Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	64.3%+1.8pp	64.3%+2.4pp	63.9%+2.4pp	63.6%+2.8pp	62.5%+1.5pp
Operating margin	10%-2.2pp	12.6%+4.8pp	15.5%+15.0pp	14.3%+17.0pp	12.3%+17.5pp
Net margin	14.3%+1.2pp	13.4%+4.8pp	16.4%+14.9pp	15.2%+17.0pp	13.1%+17.4pp
EBITDA margin	10.7%-2.3pp	13.2%+4.6pp	16.1%+14.7pp	15%+16.6pp	13%+17.1pp
Returns
Return on equity	27.1%-6.4pp	28.3%+5.4pp	38.9%+34.4pp	37.4%+42.4pp	33.5%+46.3pp
Return on assets	19%-1.8pp	19.9%+6.0pp	26.4%—	24.4%+27.1pp	20.8%+27.6pp
Return on invested capital	114.6%-211pp	167.3%-101pp	259.4%—	248.6%+292pp	325.5%+390pp
Efficiency
Asset turnover	1.3×-0.3×	1.5×-0.1×	1.6×—	1.6×0.0×	1.6×+0.1×
Inventory turnover	2.6×-0.8×	3.1×-0.1×	3.1×—	3.3×+0.4×	3.4×+0.8×
Liquidity
Current ratio	4.6×+0.9×	4.9×+1.3×	4.1×+1.2×	3.9×+1.1×	3.7×+1.1×
Quick ratio	3.6×+0.4×	3.8×+0.8×	3.3×+0.9×	3.2×+1.1×	3.1×+1.2×
Cash ratio	2.9×+0.2×	3.3×+0.8×	2.8×+1.0×	2.7×+1.1×	2.7×+1.3×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0.1×-0.1×	0.1×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-4.6×-0.9×	-3.6×+1.3×	-3×+19.9×	-3.3×—	-3.7×—
Interest coverage	7.2×-2.7×	8.5×+1.7×	9.9×+9.5×	10×+12.5×	9.8×+15.0×
Per Share
Book value per share	$0.97+46.4%	$0.90+51.8%	$0.82+84.6%	$0.74+83.1%	$0.66+72.8%
Valuation
Market capitalization	$254.07M-74.9%	$507.57M—	$744.1M—	$1.11B—	——
Enterprise value	$190.09M-79.7%	$445.58M—	$682.86M—	$1.06B—	——
Price / earnings	13.6×-43.5×	29.2×—	36.4×—	62.8×—	——
Price / sales	2×-6.8×	3.9×—	6×—	9.6×—	——
Price / book	3.3×-13.6×	6.6×—	10.5×—	17.3×—	——
EV / EBITDA	15×-44.1×	26.1×—	34×—	60.5×—	——
EV / sales	1.6×-7.3×	3.4×—	5.5×—	9.1×—	——
Earnings yield	6.8%+5.2pp	3.4%—	2.7%—	1.6%—	——
PEG ratio	0.5×—	0.3×—	0×—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Niagen Bioscience, Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Niagen Bioscience, Inc. Common Stock's profit margins?: Niagen Bioscience, Inc. Common Stock (NAGE) runs a 64.3% gross margin and a 10.0% operating margin, with a 14.3% net margin.
Where do Niagen Bioscience, Inc. Common Stock's ratios come from?: Every ratio is computed from Niagen Bioscience, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.